Search
for
Sort by
Research 91–120 of 1000+
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Management of tinea capitis in childhood
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Janus Kinase inhibitors in dermatology: a review
- Is Withania somnifera (Ashwagandha) a safe and effective treatment for reducing perimenopausal symptoms?
- Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial
- Review of Promising Off-Label Use of Deucravacitinib
- Reply to Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice
- Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature
- Comparative histomorphometric and transcriptomic analysis reveals potential genetic determinants of pelage variation between hairy and coarse-woolly sheep
- Transcriptomic Analysis of Skin Tissue Reveals Molecular Mechanisms of Thermal Adaptation in Cold-Exposed Lambs
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Hashimoto Thyroiditis - A Comprehensive Review
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Teriflunomide in multiple sclerosis: an update
- Tregs: Where We Are and What Comes Next?
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Alopecia areata mit gutem Ansprechen auf Tofacitinib
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- The JAK/STAT signaling pathway: from bench to clinic
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- PP405 in Alopecia: An Emerging Molecule worth Investigating
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients
- Advances in clinical applications of microneedle